StevenCGoldsteinMD

PubMed

• 37 citations
  Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung
  Sameem Abedin, Gregory A. Yanik, Thomas Braun, Attaphol Pawarode, John M. Magenau, Steven C. Goldstein, John E. Levine, Carrie L. Kitko, Daniel R. Couriel> ;Biology of Blood and Marrow Transplantation. 2015 Jun 1
• Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic...
  Maziarz, R. T.,Devos, T.,Bachier, C. R.,Goldstein, S. C.,Leis, J. F.,Devine, S. M.,Meyers, G.,Gajewski, J. L.,Maertens, J.,Deans, R. J.,Van't Hof, W.,Lazarus, H. M.> ;Biol. Blood Marrow Transplant.. 2015 Jan 04
• Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for Inter...
  Hsu, J. W.,Wingard, J. R.,Logan, B. R.,Chitphakdithai, P.,Akpek, G.,Anderlini, P.,Artz, A. S.,Bredeson, C.,Goldstein, S.,Hale, G.,Hematti, P.,Joshi, S.,Kamble, R. T.,L...> ;Biol. Blood Marrow Transplant.. 2014 Oct 16
• Phase III clinical trial steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute graft-versus-host disease: BMT CTN 0802.
  Bolaños-Meade, J.,Logan, B. R.,Alousi, A. M.,Antin, J. H.,Barowski, K.,Carter, S. L.,Goldstein, S. C.,Hexner, E. O.,Horowitz, M. M.,Lee, S. J.,Levine, J. E.,MacMillan,...> ;Blood. 2014 Aug 30
• Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
  Landsburg, D. J.,Stadtmauer, E.,Loren, A.,Goldstein, S.,Frey, N.,Nasta, S. D.,Porter, D. L.,Tsai, D. E.,Perl, A. E.,Hexner, E. O.,Luger, S.> ;Am. J. Hematol.. 2013 Aug
• A Pilot Study of Prophylactic Ex Vivo Co-Stimulated Donor Leukocyte Infusions After Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation.
  Kumar, A. J.,Hexner, E. O.,Frey, N. V.,Luger, S. M.,Loren, A. W.,Reshef, R.,Boyer, J.,Smith, J.,Stadtmauer, E. A.,Levine, B. L.,June, C. H.,Porter, D. L.,Goldstein, S. C.> ;Biol. Blood Marrow Transplant.. 2013 Jul
• Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
  Pulsipher, M. A.,Chitphakdithai, P.,Logan, B. R.,Shaw, B. E.,Wingard, J. R.,Lazarus, H. M.,Waller, E. K.,Seftel, M.,Stroncek, D. F.,Lopez, A. M.,Maharaj, D.,Hematti, P...> ;Blood. 2013 Jan 3
• Structural and biosynthetic features of the Mo5 human myeloid differentiation antigen.
  Goldstein, S. C., Todd, R. F.> ;Tissue Antigens. 1993 Apr
• Human cytomegalovirus (HCMV) enhances bovine papilloma virus (BPV) transformation in vitro.
  Goldstein, S. C., Byrne, J. C., Rabson, A. S.> ;J Med Virol. 1987 Oct
• Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.
  Rager, A., Frey, N., Goldstein, S. C., Reshef, R., Hexner, E. O., Loren, A., Luger, S. M., Perl, A., Tsai, D., Davis, J., Vozniak, M., Smith, J., Stadtmauer, E. A., Po...> ;Bone Marrow Transplant. 2011 Mar
• Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
  Loren, A. W., Luger, S. M., Stadtmauer, E. A., Tsai, D. E., Schuster, S., Nasta, S. D., Goldstein, S. C., Perl, A., Orloff, G., Oliver, J. C., Green, J., Emerson, S. G...> ;Bone Marrow Transplant. 2005 May
• Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer.
  Fields, K. K., Elfenbein, G. J., Perkins, J. B., Ballester, O. F., Goldstein, S. C., Heimenz, J. W., Saez, R. A., Sullivan, D. M., Partyka, J. S., Kronish, L. A.> ;Semin Oncol. 1998 Apr
• Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.
  Andreadis, C., Schuster, S. J., Chong, E. A., Svoboda, J., Luger, S. M., Porter, D. L., Tsai, D. E., Nasta, S. D., Elstrom, R. L., Goldstein, S. C., Downs, L. H., Mang...> ;Bone Marrow Transplant. 2005 Dec
• Has allogeneic stem cell cryopreservation been given the ''cold shoulder''? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogen...
  Frey, N. V., Lazarus, H. M., Goldstein, S. C.> ;Bone Marrow Transplant. 2006 Sep
• Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation.
  Agaliotis, D. P., Ballester, O. F., Mattox, T., Hiemenz, J. W., Fields, K. K., Zorsky, P. E., Goldstein, S. C., Perkins, J. B., Rosen, R. M., Elfenbein, G. J.> ;Am J Med Sci. 1997 Nov
• Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myeloma.
  Ballester, O. F., Moscinski, L. C., Fields, K. K., Hiemenz, J. W., Zorsky, P. E., Goldstein, S. C., Saba, H. I., Spiers, A. S., Kronish, L., Sullivan, P., Elfenbein, G...> ;Br J Haematol. 1997 Mar
• Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicitie...
  Ballester, O. F., Agaliotis, D. P., Hiemenz, J. W., Janssen, W. E., Fields, K. K., Zorksy, P. E., Goldstein, S. C., Perkins, J. B., Elfenbein, G. J.> ;Bone Marrow Transplant. 1996 Jul
• High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
  Ballester, O. F., Tummala, R., Janssen, W. E., Fields, K. K., Hiemenz, J. W., Goldstein, S. C., Perkins, J. B., Sullivan, D. M., Rosen, R., Sackstein, R., Zorsky, P., ...> ;Bone Marrow Transplant. 1997 Oct
• Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlates.
  Perkins, J. B., Goldstein, S. C., Dawson, J. L., Kim, J., Field, T. L., Partyka, J. S., Fields, K. K., Maddox, B. L., Simonelli, C. E., Neuger, A. M., Lush, R. M., Sul...> ;Clin Cancer Res. 2011 Dec 15
• NMR metabolic and physiological markers of therapeutic response.
  Lee, S. C., Poptani, H., Delikatny, E. J., Pickup, S., Nelson, D. S., Schuster, S. J., Nasta, S. D., Svoboda, J., Goldstein, S. C., Wallace, S. G., Loevner, L. A., Mel...> ;Adv Exp Med Biol. 2011
• Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.
  Goldstein, S. C., Porter, D. L.> ;Expert Rev Hematol. 2010 Jun
• Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
  Metayer, C., Curtis, R. E., Vose, J., Sobocinski, K. A., Horowitz, M. M., Bhatia, S., Fay, J. W., Freytes, C. O., Goldstein, S. C., Herzig, R. H., Keating, A., Miller,...> ;Blood. 2003 Mar 1
• A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
  Lazarus, H. M., Zhang, M. J., Carreras, J., Hayes-Lattin, B. M., Ataergin, A. S., Bitran, J. D., Bolwell, B. J., Freytes, C. O., Gale, R. P., Goldstein, S. C., Hale, G...> ;Biol Blood Marrow Transplant. 2010 Jan
• A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
  Perl, A. E., Kasner, M. T., Tsai, D. E., Vogl, D. T., Loren, A. W., Schuster, S. J., Porter, D. L., Stadtmauer, E. A., Goldstein, S. C., Frey, N. V., Nasta, S. D., Hex...> ;Clin Cancer Res. 2009 Nov 01
• Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner:...
  Mellon, E. A., Lee, S. C., Pickup, S., Kim, S., Goldstein, S. C., Floyd, T. F., Poptani, H., Delikatny, E. J., Reddy, R., Glickson, J. D.> ;Magn Reson Med. 2009 Dec 01
• Join now to see all